Berkenblit Anna 4
4 · ImmunoGen, Inc. · Filed Feb 8, 2022
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Berkenblit Anna
VP & Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-04$5.32/sh+311,700$1,658,244→ 311,700 totalExercise: $5.32From: 2023-02-04Exp: 2032-02-04→ Common Stock (311,700 underlying)
Footnotes (1)
- [F1]These options vest over a four-year period, with 25% of the shares vesting on the one year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.